Income after Taxes: Earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
Alterity Therapeutics Limited - Sponsored ADR (ATHE) had Income after Taxes of $-15.88M for the most recently reported fiscal year, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-15.88M |
|
-- |
|
-- |
|
$19.24M |
|
$-19.24M |
|
$3.44M |
|
$-15.81M |
|
$-15.81M |
|
|
Income after Taxes |
$-15.88M |
$-15.88M |
|
$-15.88M |
|
$-15.88M |
|
$-19.24M |
|
$-19.16M |
|
17.54M |
|
17.54M |
|
$-0.91 |
|
$-0.91 |
|
| Balance Sheet Financials | |
$31.10M |
|
$0.00M |
|
$0.13M |
|
$31.23M |
|
$2.14M |
|
-- |
|
$0.09M |
|
$2.24M |
|
$29.00M |
|
$29.00M |
|
$29.00M |
|
18.13M |
|
| Cash Flow Statement Financials | |
$-15.29M |
|
$5.09M |
|
$12.98M |
|
$22.50M |
|
$25.33M |
|
$2.82M |
|
$3.05M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
14.52 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-15.29M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-54.77% |
|
-54.77% |
|
-50.85% |
|
-54.77% |
|
$1.60 |
|
$-0.87 |
|
$-0.87 |
|